Participant Demographics
Study size
Over 1,300 patients from the Southern, Eastern and Midwest regions of the United States currently participate in this study.
When the study began in 2014, we followed participants up to 25 years of age. In an effort to capture data from the full life span of patients with sickle cell disease, we expanded the age cohort to enroll and follow participants from birth through adulthood.